GENETIC TECHNOLOGIES LTD

Overview

• IndustryBiological Products, (No Diagnostic Substances)¹
• Business addressSuite 7, Level 1, 321 Chapel Street, Prahran Victoria, C3 3181²
• Filer categoryNon-accelerated filer²

See how the biggest companies compare on our leaderboards

Ohio State University, reflecting the growing awareness of the Company’s expertise in SNP- based risk assessment.³ From its latest annual report

Corporate structure

GENETIC TECHNOLOGIES LTD sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Former names

• GENETIC TECHNOLOGIES LTD /FIDec 5, 2001 to Dec 30, 2002²

Filings

121 filings to the SEC since October 2021: 3 annual reports, 2 large holders, 116 other. The latest 20:

1. May 12, 202525-NSE EDGAR
2. Dec 12, 20246-K EDGAR
3. Dec 2, 20246-K EDGAR
4. Nov 20, 20246-K EDGAR
5. Oct 31, 20246-K EDGAR
6. Oct 28, 20246-K EDGAR
7. Oct 1, 20246-K EDGAR
8. Oct 1, 20246-K EDGAR
9. Sep 30, 202420-F EDGAR
10. Sep 11, 20246-K EDGAR
11. Aug 28, 20246-K EDGAR
12. Aug 15, 20246-K EDGAR
13. Jul 31, 20246-K EDGAR
14. Jul 26, 20246-K EDGAR
15. Jun 28, 20246-K EDGAR
16. Jun 28, 20246-K EDGAR
17. Jun 21, 20246-K EDGAR
18. Jun 5, 20246-K EDGAR
19. May 29, 20246-K EDGAR
20. May 24, 2024EFFECT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• CVI Investments, Inc.SC 13G/A, 2 filings Feb 13, 2023 to Feb 14, 2024¹¹

SEC filer profile

How GENETIC TECHNOLOGIES LTD is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARGENETIC TECHNOLOGIES LTD¹
• CIK0001166272
• Filer statusNon-accelerated filer¹
• Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business addressSuite 7, Level 1, 321 Chapel Street, Prahran Victoria, C3 3181¹
• Phone011613-9415-1135¹
• Shares outstanding132,217,246 as of Jun 30, 2024⁴
• On EDGAR sinceDec 5, 2001¹
• Filings701 in all: 6-K (591), 20-F (20), SC 13G (11), SC 13G/A (11), 424B5 (10), EFFECT (7), SUPPL (7), UPLOAD (7)¹
  All 25 form types

  424B3 (6), CORRESP (6), F-3 (5), ARS (3), 20-F/A (2), 20FR12G/A (2), F-1 (2), F-1/A (2), 12G3-2B (1), 20FR12G (1), 25-NSE (1), 424B4 (1), 6-K/A (1), CT ORDER (1), F-3/A (1), F-6EF (1), NT 20-F (1)

• Latest filingsAnnual report (20-F) Sep 30, 2024